ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TEVA Teva Pharmaceutical Industries Ltd

13.8107
-0.1693 (-1.21%)
07 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Teva Pharmaceutical Industries Ltd NYSE:TEVA NYSE Depository Receipt
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  -0.1693 -1.21% 13.8107 14.11 13.88 13.95 9,146,663 01:00:00

ADRs End Higher; JA Solar, NetEase Trade Actively

17/11/2017 11:31pm

Dow Jones News


Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Teva Pharmaceutical Indu... Charts.

International stocks trading in New York closed higher on Friday.

The BNY Mellon index of American depositary receipts rose 0.3% to 149.50. The European index increased 0.2% to 137.96. The Asian index improved 0.1% to 178.63. The Latin American index increased 1.3% to 241.13. And the emerging-markets index increased 0.6% to 325.05.

JA Solar Holdings Co. (JASO), NetEase Inc. (NTES), and Teva Pharmaceutical Industries Ltd. (TEVA) were among those with ADRs that traded actively.

Chinese solar company JA Solar said Friday it has agreed to be taken private by an investor consortium in an all-cash deal, implying an equity value of the company at $362.1 million. The consortium is headed by Baofang Jin, CEO of the Jinglong, a British Virgin Islands company, and other rollover shareholders. The deal is expected to close in the first quarter of 2018. ADRs rose 8.5% to $7.45.

Chinese online-gaming company NetEase beat market expectations in third-quarter results reported Wednesday, helped by a lower effective tax rate. The company's third-quarter earnings were 5% above consensus and operating margin was largely in line with estimates. Analysts from Bank of America also raised their per-share price target on NetEase to $361 from $347. ADRs rose 13% to $367.50.

Israeli pharmaceutical company Teva announced this week a new prescription copay savings program for generic Gleevec tablets. ADRS rose 8.2% to $13.84.

 

(END) Dow Jones Newswires

November 17, 2017 18:16 ET (23:16 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

1 Year Teva Pharmaceutical Indu... Chart

1 Year Teva Pharmaceutical Indu... Chart

1 Month Teva Pharmaceutical Indu... Chart

1 Month Teva Pharmaceutical Indu... Chart

Your Recent History

Delayed Upgrade Clock